News & Press

Protenus Awarded Drug Diversion Software Solutions Agreement with Premier, Inc.

Offering Premier members access to the Protenus award-winning solution to support hospital diversion prevention and compliance programs 

Protenus has been awarded a national group purchasing agreement for Drug Diversion Software Solutions with Premier, Inc.   Effective March 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Protenus Drug Diversion Software Surveillance solution. 

Nick Culbertson, CEO and Co-founder of Protenus, states,

Some of the largest health systems and academic medical centers across the U.S. depend on our solutions to preemptively detect inappropriate behavior linked to drug diversion. We're honored to be a Premier Contracted Supplier and are excited about collaborating with Premier members to support their objectives in the monitoring and eradicating risks of drug diversion within their organizations.”

Protenus Drug Diversion Surveillance patented technology supports efficient workforce automation, and enables hospitals to do more than humanly possible using fewer resources to accurately, reliably, and quickly detect drug diversion. By auditing up to 100% of medical use transactions, healthcare organizations are able to surface inappropriate behavior that may otherwise go unnoticed, and identify the early warning signs of an incident, strengthening their policy adherence strategy. 

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost. 

Premier members may reference Protenus Supplier contract PPPH27PRO01 for more information.

About Protenus

Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus was awarded Best in KLAS for both patient privacy monitoring and drug diversion surveillance solutions two years in a row (2023-2024), is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at and follow us on X (Twitter) @Protenus.

Media Contact:

Michelle Del Guercio
Chief Marketing Officer